Abstract
We have performed a methylation-specific PCR approach to comparatively analyze the MGMT promoter methylation status in 186 glioblastomas (GBM) from patients with classic survival and nine from patients with long-term survival (LTS GBM). The methylation rate in LTS GBM was significantly higher (77.8% vs. 39.2%, P = 0.033) which suggests that MGMT hypermethylation is a frequent hallmark of LTS GBM and contributes to characterize this intriguing GBM subtype.
Original language | English (US) |
---|---|
Pages (from-to) | 91-93 |
Number of pages | 3 |
Journal | Journal of Neuro-Oncology |
Volume | 83 |
Issue number | 1 |
DOIs | |
State | Published - May 2007 |
ASJC Scopus subject areas
- Clinical Neurology
- Cancer Research
- Oncology
- General Neuroscience